Skip to main

Acorda Therapeutics

ACOR is nowACORQ
ACOR logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More

Frequently Asked Questions (FAQ)

As of Jul 27, 2025, the market cap for ACOR stock is $500

The 52-week high for ACOR stock is $0.00. The current ACOR stock price $undefined is 100.00% below its 52-week high

No, the ACOR stock does not pay dividends to its shareholders

The target price for ACOR stock is $30.62 based on the average of what a group of analyst think ACOR stock could be worth at a future date. This is not a prediction by Public.com

How to buy ACOR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ACOR stock

    Navigate to the Explore page. Then, type ACOR into the search bar. When you see ACOR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ACOR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Acorda Therapeutics Stock Earnings

The value each ACOR share was expected to gain vs. the value that each ACOR share actually gained.

Acorda Therapeutics (ACOR) reported Q3 2021 earnings per share (EPS) of -$28.60, beating estimates of -$31.20 by 8.33%. In the same quarter last year, Acorda Therapeutics's earnings per share (EPS) was -$27.60. Acorda Therapeutics is expected to release next earnings on 11/13/2023, with an earnings per share (EPS) estimate of $0.

Buy Acorda Therapeutics (ACOR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.